Home › Kanser sa Suso › Oregon › Beaverton

Pag-aaral pangklinika para sa Kanser sa Suso sa Beaverton, OR

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Beaverton. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Providence Newberg Medical Center, Newberg · 15 mi ang layo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Nagre-recruitPhase 3

Northwest Cancer Specialists (Compass Oncology) ( Site 8010), Tigard · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06966700

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Nagre-recruitPhase 3

Northwest Cancer Specialists, P.C., Tigard · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06492616

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Nagre-recruitPhase 2

Northwest Cancer Specialists (Compass Oncology) ( Site 8003), Tigard · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06797635

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3

Providence Newberg Medical Center, Newberg · 15 mi ang layo

Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Nagre-recruitPhase 3

Compass Oncology - Northwest Cancer Specialists, Tigard · 4 mi ang layo

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

Nagre-recruitPhase 3

Providence Newberg Medical Center, Newberg · 15 mi ang layo

Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06748222

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Nagre-recruitPhase 3

Legacy Meridian Park Hospital, Tualatin · 7 mi ang layo
Providence Newberg Medical Center, Newberg · 15 mi ang layo

Edad 50 hanggang 70 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT04852887

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Beaverton

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.